These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19336455)

  • 21. Activation and inhibition of CTP synthase from Trypanosoma brucei, the causative agent of African sleeping sickness.
    Steeves CH; Bearne SL
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5188-90. PubMed ID: 21840216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clomipramine kills Trypanosoma brucei by apoptosis.
    de Silva Rodrigues JH; Stein J; Strauss M; Rivarola HW; Ueda-Nakamura T; Nakamura CV; Duszenko M
    Int J Med Microbiol; 2016 Jun; 306(4):196-205. PubMed ID: 27086198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidosqualene cyclase inhibitors as antimicrobial agents.
    Hinshaw JC; Suh DY; Garnier P; Buckner FS; Eastman RT; Matsuda SP; Joubert BM; Coppens I; Joiner KA; Merali S; Nash TE; Prestwich GD
    J Med Chem; 2003 Sep; 46(20):4240-3. PubMed ID: 13678402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico drug re-purposing against African sleeping sickness using GlcNAc-PI de-N-acetylase as an experimental target.
    Rashmi M; Swati D
    Comput Biol Chem; 2015 Dec; 59 Pt A():87-94. PubMed ID: 26476127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Closing in on a new treatment for sleeping sickness.
    Derbyshire ER; Clardy J
    Elife; 2013 Jul; 2():e01042. PubMed ID: 23853715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing.
    Diaz-Gonzalez R; Kuhlmann FM; Galan-Rodriguez C; Madeira da Silva L; Saldivia M; Karver CE; Rodriguez A; Beverley SM; Navarro M; Pollastri MP
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1297. PubMed ID: 21886855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazones.
    Papanastasiou I; Tsotinis A; Zoidis G; Kolocouris N; Prathalingam SR; Kelly JM
    ChemMedChem; 2009 Jul; 4(7):1059-62. PubMed ID: 19422003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput whole genome analysis provides insight into how the major drugs against African sleeping sickness operate.
    Rudenko G
    Pathog Glob Health; 2012 May; 106(2):79. PubMed ID: 22943541
    [No Abstract]   [Full Text] [Related]  

  • 29. C1'-Branched acyclic nucleoside phosphonates mimicking adenosine monophosphate: Potent inhibitors of Trypanosoma brucei adenine phosphoribosyltransferase.
    Kalčic F; Frydrych J; Doleželová E; Slapničková M; Pachl P; Slavětínská LP; Dračínský M; Hocková D; Zíková A; Janeba Z
    Eur J Med Chem; 2021 Dec; 225():113798. PubMed ID: 34482272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitors.
    Masand VH; El-Sayed NN; Mahajan DT; Rastija V
    SAR QSAR Environ Res; 2017 Feb; 28(2):165-177. PubMed ID: 28235390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Andrographolide induces oxidative stress-dependent cell death in unicellular protozoan parasite Trypanosoma brucei.
    Banerjee M; Parai D; Dhar P; Roy M; Barik R; Chattopadhyay S; Mukherjee SK
    Acta Trop; 2017 Dec; 176():58-67. PubMed ID: 28739368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5'-carboxamidoadenosine analogues.
    Rodenko B; Detz RJ; Pinas VA; Lambertucci C; Brun R; Wanner MJ; Koomen GJ
    Bioorg Med Chem; 2006 Mar; 14(5):1618-29. PubMed ID: 16249090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independence from Kinetoplast DNA maintenance and expression is associated with multidrug resistance in Trypanosoma brucei in vitro.
    Gould MK; Schnaufer A
    Antimicrob Agents Chemother; 2014 May; 58(5):2925-8. PubMed ID: 24550326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488.
    Smith VC; Cleghorn LA; Woodland A; Spinks D; Hallyburton I; Collie IT; Mok NY; Norval S; Brenk R; Fairlamb AH; Frearson JA; Read KD; Gilbert IH; Wyatt PG
    ChemMedChem; 2011 Oct; 6(10):1832-40. PubMed ID: 21834094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metal-chelating agents against viruses and parasites.
    Giannakopoulou E; Pardali V; Zoidis G
    Future Med Chem; 2018 Jun; 10(11):1283-1285. PubMed ID: 29719970
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel 2H-isoquinolin-3-ones as antiplasmodial falcipain-2 inhibitors.
    Micale N; Ettari R; Schirmeister T; Evers A; Gelhaus C; Leippe M; Zappalà M; Grasso S
    Bioorg Med Chem; 2009 Sep; 17(18):6505-11. PubMed ID: 19709887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Antitrypanosomal Activity of the Secondary Metabolites from the Mutant Strain IU-3 of the Insect Pathogenic Fungus Ophiocordyceps coccidiicola NBRC 100683.
    Ganaha M; Yoshii K; Ōtsuki Y; Iguchi M; Okamoto Y; Iseki K; Ban S; Ishiyama A; Hokari R; Iwatsuki M; Otoguro K; Ōmura S; Hashimoto T; Noji M; Umeyama A
    Chem Pharm Bull (Tokyo); 2016; 64(7):988-90. PubMed ID: 27373660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of calcium in trypanocidal drug action.
    Clarkson AB; Amole BO
    Science; 1982 Jun; 216(4552):1321-3. PubMed ID: 6805075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy for sleeping sickness: a wake-up call.
    Pepin J
    J Infect Dis; 2007 Feb; 195(3):311-3. PubMed ID: 17205466
    [No Abstract]   [Full Text] [Related]  

  • 40. Trypanocidal and antileishmanial dihydrochelerythrine derivatives from Garcinia lucida.
    Fotie J; Bohle DS; Olivier M; Adelaida Gomez M; Nzimiro S
    J Nat Prod; 2007 Oct; 70(10):1650-3. PubMed ID: 17880175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.